Treatment of somatization disorder with nefazodone: A prospective, open-label study

Annals of Clinical Psychiatry

Volumn 13, Issue 3, 2001, Pages 153-158

  Menza, M ^a   Lauritano, M ^a   Allen, L ^a   Warman, M ^a   Ostella, F ^a   Hamer, R M ^a   Escobar, J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Abridged somatization; Antidepressants; Nefazodone; Somatization; Somatization disorder

Indexed keywords

NEFAZODONE;

ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; DYSTHYMIA; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SEDATION; SELF CONCEPT; SIDE EFFECT; SOMATIZATION; STATISTICAL ANALYSIS; XEROSTOMIA;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS; TREATMENT OUTCOME; TRIAZOLES;

EID: 0035669242     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012285524965     Document Type: Article

References (31)

1. Somatization in the community
2. Somatization disorder in a community population
3. Somatization in primary care. Prevalence, health care utilization, and general practitioner recognition
4. The course of somatization and its effects on utilization of health care resources
5. Unexplained physical complaints: Psychopathology and epidemiological correlates
6. Somatization in the community: Relationship to disability and use of services
7. Abridged Somatization A study in primary care
8. Antidepressant therapy for unexplained symptoms and symptom syndromes
9. Physical symptoms in primary care: Predictors of psychiatric disorder and functional impairment
10. The epidemiology and treatment of depression when it coexists with somatoform disorders, somatization, of pain
11. Fluvoxamine for somatoform disorders: An open trial
12. Pharmacologic treatment of somatization/hypochondriasis. Overview of somatization; diagnosis, epidemiology, and management
13. Somatization. A debilitating syndrome in primary care
14. Nefazodone: Aspects of efficacy
15. An open trial of nefazodone in adult patients with generalized anxiety disorder
16. Nefazodone in social phobia
17. Nefazodone in patients with treatment-refractory posttraumatic stress disorder
18. The effect of nefazodone on comorbid anxiety symptoms associated with depression: Experience in family practice and psychiatric outpatient settings
19. Nefazodone for patients with chronic fatigue syndrome
20. Medically unexplained physical symptoms, somatization disorder and abridged somatization Studies with the Diagnostic Interview Schedule
21. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition
22. The composite international diagnostic interview
23. The rand 36-item health survey 1.0
24. Hamilton depression scale
25. The assessment of anxiety status by rating
26. The acceptability of psychological treatment in patients with medically unexplained physical symptoms
27. Functional somatic syndromes
28. Secondary affective disorder in women with somatization